Embla Medical hf. (CPH:EMBLA)
Denmark flag Denmark · Delayed Price · Currency is DKK
29.40
-0.10 (-0.34%)
Aug 28, 2026, 4:59 PM CET

Embla Medical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
93.9583.3468.2858.3942.5163.99
Depreciation & Amortization
54.3154.7249.443.3343.4945.54
Other Amortization
8.945.96.586.595.875.99
Asset Writedown & Restructuring Costs
-----0.12
Other Operating Activities
-12.01-5.612.37-2.88-11.826.5
Change in Accounts Receivable
-6.85-12.32-5.52-16.37-13.2-13.18
Change in Inventory
-0.14-8.59-5.93-2.27-28.62-15.78
Change in Accounts Payable
1.7711.33-2.2814.910.947.76
Change in Other Net Operating Assets
2.983.863.17-7.3711.58-0.4
Operating Cash Flow
142.95132.62116.0794.3260.77100.53
Operating Cash Flow Growth
19.57%14.26%23.05%55.21%-39.55%8.99%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-17.01-22.07-27.03-29.23-16.55-16.96
Cash Acquisitions
-14.97-14.69-70.07-11.9-41.78-33.94
Sale (Purchase) of Intangibles
-10.26-10.26-12.19-13.05-9.4-9.73
Other Investing Activities
-20.410.94.53-2.971.471.18
Investing Cash Flow
-62.65-46.13-104.77-57.15-66.26-59.45

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-57.4639.79-101.421.69
Long-Term Debt Repaid
--117.33-24.38-40.2-87.06-51.44
Net Debt Issued (Repaid)
-57.11-59.8715.41-40.214.36-49.74
Repurchase of Common Stock
-13.62-9.75---9.94-
Other Financing Activities
-5.16-5.16-9.65-0.76-0.63-1.33
Financing Cash Flow
-75.89-74.785.76-40.963.79-51.07

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.264.63-3.55-0.2-6.86-7.18
Miscellaneous Cash Flow Adjustments
---0--0-
Net Cash Flow
4.6616.3413.51-3.98-8.57-17.17

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
125.93110.5589.0365.0944.2283.57
Free Cash Flow Growth
27.86%24.16%36.78%47.19%-47.08%6.50%
Free Cash Flow Margin
12.79%11.90%10.42%8.29%6.15%11.63%
Free Cash Flow Per Share
0.290.260.210.150.110.20
Levered Free Cash Flow
95.68108.4769.4724.4852.479.11
Unlevered Free Cash Flow
107.93120.678435.759.485.23

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
20.7520.5524.0816.0513.1112.15
Cash Income Tax Paid
30.5426.623.4920.3519.6616.3
Change in Working Capital
-2.24-5.73-10.56-11.11-19.29-21.61